Julius Clinical
Kasper Bunschoten is a seasoned Senior Business Analyst at Julius Clinical, where expertise includes acting as an IT Business Partner for the Management Team and leading complex cross-departmental project implementations. Responsibilities encompass advising on company-wide solutions, preparing business cases, designing and configuring process management systems, and overseeing change management. Previous roles include Medior Business Analyst and Process Analyst, as well as an Advisor for Quality Improvement at Astrea, where a quality enhancement method was developed. Early career experience includes serving as Team Captain at Streetwise Fundraising. Kasper holds an MSc in Business Administration with a focus on Operations and Supply Chain Management from the University of Groningen and has completed additional training at Schouten en Nelissen and Capgemini Academy.
This person is not in any teams
Julius Clinical
At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs. Our skilled and loyal networks of investigators all around the world allow us to offer superior recruitment in therapeutic area’s such as cardiology, diabetes, CNS and infectious diseases. Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. This type of demanding research requires more than a ‘one-size-fits-all’ approach, and our fusion of scientific and operational expertise enables to deliver results efficiently, on time and budget. Julius Clinical has on its staff internationally recognised academic leaders who are actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility, combined with personal links with peers around the world, means that the company has a truly global reach and reputation. Through our global networks we can quickly select the most appropriate and high-performing sites to take part in a trial, and ensure that investigators are inspired and motivated.